Welcome to our dedicated page for Ontrak news (Ticker: OTRK), a resource for investors and traders seeking the latest updates and insights on Ontrak stock.
Ontrak Inc (OTRK) delivers AI-powered behavioral healthcare solutions through its proprietary PRE platform, addressing chronic conditions exacerbated by untreated mental health factors. This page serves as the definitive source for official company announcements and strategic developments.
Access timely updates including earnings reports, partnership agreements, regulatory milestones, and technology innovations. Our curated news collection enables investors to track Ontrak's progress in integrating predictive analytics with personalized care delivery models.
Discover updates on key operational areas: clinical program expansions, payer partnership developments, and advancements in telehealth integration. All content is sourced directly from verified company communications to ensure accuracy and compliance.
Bookmark this page for streamlined access to Ontrak's evolving role in value-based care initiatives and behavioral health technology. Monitor how the company's data-driven approach continues to shape chronic disease management strategies across healthcare ecosystems.
Ontrak, Inc. (NASDAQ: OTRK) announced the publication of its Treatment Effect Study in the American Journal of Managed Care. The study reports a significant $485 PMPM savings over 24 months, mainly from a 66% reduction in inpatient visits among 900 members enrolled in the Ontrak WholeHealth+ program. Key findings include sustained savings, increased office visits, and a push toward integrating behavioral health interventions in the healthcare system to support value-based care. These results validate Ontrak's approach to improving healthcare outcomes.
On December 6, 2022, Ontrak, Inc. (OTRK, OTRKP) received a notice from Nasdaq indicating non-compliance with the minimum bid price requirement, having traded below $1.00 for 30 consecutive business days. The company has a 180-day grace period until June 5, 2023, to restore compliance by achieving a minimum closing bid price of $1.00 for at least 10 consecutive days. There is no immediate impact on the stock's listing, but the company is exploring options to regain compliance, with no assurance of success.
Ontrak, Inc. (NASDAQ: OTRK) reported Q3 2022 revenue of $2.8 million, an 85% decline compared to the previous year. The company experienced a net loss of $(12.8) million, or $(0.62) per share. To enhance its financial position, Ontrak fully repaid a $7.5 million loan and secured $3.3 million in a direct share offering. The company confirmed its 2022 revenue outlook of $14 to $16 million and noted progress in its sales pipeline, aiming for growth in 2023. Adjusted EBITDA was $(7.7) million, up from $(1.7) million in Q3 2021.
Ontrak, Inc. (NASDAQ: OTRK) will report its third-quarter 2022 financial results on November 9, 2022, after market close. A conference call will be held at 1:30 p.m. PT / 4:30 p.m. ET. Investors can access the call via registration or through a live audio webcast. Ontrak leverages AI and telehealth to support behavioral health, emphasizing personalized care for vulnerable populations dealing with anxiety, depression, and substance use disorders.
Ontrak, Inc. (NASDAQ: OTRK) announced the appointment of James Messina as a non-Executive Director to its board. With extensive experience in healthcare, Messina previously served as Executive VP and COO for Premera Blue Cross and held leadership roles at CIGNA and UnitedHealth Group. His expertise is expected to enhance Ontrak’s mission of improving behavioral health services. Terren Peizer, CEO, expressed enthusiasm for Messina's contributions, emphasizing the importance of tailored support for individuals with behavioral health needs.
Ontrak, Inc. (NASDAQ: OTRK) has announced its participation in the Inaugural Gilmartin Group Emerging Growth Company Showcase, set for August 31, 2022, at 1:00 p.m. ET. The virtual event will feature a presentation by company management. Interested parties can access the live webcast here, and an archived version will be available on the company’s website, highlighting Ontrak's mission to improve healthcare for vulnerable populations using AI and telehealth solutions.
Ontrak, Inc. (NASDAQ: OTRK) reported Q2 2022 revenue of $3.9 million, an 85% decrease from the previous year, with a net loss of $15.1 million ($0.83 per share).
To manage its finances, the company fully repaid a $19.2 million loan, with a $5 million draw from its Keep Well Agreement.
Ontrak raised $3.5 million via a registered direct offering and partnered with Eleos for AI integration, reflecting progress in their sales pipeline with 19 health plan prospects.
The company forecasts 2022 revenue between $14 million and $16 million.
Ontrak, Inc. (NASDAQ: OTRK) has completed a registered direct offering, raising approximately
Ontrak, Inc. (NASDAQ: OTRK) announced a securities purchase agreement for a registered direct offering of its common stock at $0.80 per share, raising approximately $4.0 million before fees. The offering, expected to close by August 4, 2022, aims to fund working capital and reduce debt. Roth Capital Partners serves as the exclusive placement agent. The shares are being offered under a previously filed shelf registration statement with the SEC.
Ontrak, Inc. (NASDAQ: OTRK) announced it will release its financial results for Q2 2022 on August 9, 2022, after market close. The company will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss these results. As a leading AI and telehealth-enabled healthcare provider, Ontrak focuses on improving behavioral health outcomes for vulnerable populations through personalized care pathways and predictive analytics.
FAQ
What is the current stock price of Ontrak (OTRK)?
What is the market cap of Ontrak (OTRK)?
